How Big is the Oncology Molecular Diagnostics Market | Suppliers & Manufacturers 2025

What is the size of Oncology Molecular Diagnostics Market?

The primary forces driving this growth are the rising incidence of cancer, an increasing demand for early and exact detection methods, and technological improvements in genetic sequencing capabilities that allow for personalized treatment plans and increased likelihood for positive patient outcomes.

Growth Factors for Oncology Molecular Diagnostics Industry

• Growing proliferation of personalization in cancer treatment.
• Improved accuracy in diagnosis with new technologies in next-generation sequencing.
• Growing awareness of early cancer detection in the health care profession.
• Integration of liquid biopsy techniques for non-invasive testing.
• Partnerships between diagnostic firms and oncology research institutions.

Oncology Molecular Diagnostics Market Trends

The oncology molecular diagnostics market trends indicate a strong emphasis on precision-based detection tools, with liquid biopsy, next-generation sequencing, and multiplex PCR gaining notable traction. The increasing clinician preference for minimally invasive testing has also shaped product innovation as well as reduced the diagnostic timeframes for a number of cancers.

Moreover, oncology molecular diagnostics market understanding shows growing implementation levels in both community-based and tertiary hospital settings. The ongoing increase in the use of companion diagnostics to match targeted therapies to a specific patient profile is enabling faster uptake into the markets with the help of digital pathology and AI interpretation tools.

Emerging Developments in the Oncology Molecular Diagnostics Market

The oncology molecular diagnostics market developments are centered on expanding the clinical applications of genomic profiling beyond late-stage cancers to early screening programs. Firms are launching diagnostic panels that can identify multiple cancer types with a single test for a more efficient process for health systems. 

The oncology molecular diagnostics market has also seen developments with new merger deals and licensing agreements to expand assay offerings. Plus, we are seeing artificial intelligence (AI) used for data interpretation and efforts to automate some sample processing that improve accuracy and decrease oncology turnaround times.

List of Leading Companies in the Oncology Molecular Diagnostics Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Roche Diagnostics

Roche Diagnostics offers advanced molecular tests for cancer detection, monitoring, and companion diagnostics, enabling precision medicine and improving patient outcomes in oncology care.

2. Qiagen N.V.

Qiagen provides sample-to-insight molecular diagnostic solutions for oncology, including liquid biopsy and PCR-based tests for early detection and personalized treatment guidance.

3. Illumina, Inc.

Illumina specializes in next-generation sequencing platforms for cancer genomics, enabling comprehensive tumor profiling and guiding targeted therapy selection in oncology diagnostics.

4. Thermo Fisher Scientific Inc.

Thermo Fisher offers molecular diagnostic tools, including NGS and PCR-based cancer testing solutions, advancing precision oncology and research-driven cancer treatment decisions.

5. Guardant Health, Inc.

Guardant Health develops liquid biopsy tests for early cancer detection, therapy selection, and recurrence monitoring through advanced genomic analysis of circulating tumor DNA.

6. Foundation Medicine, Inc.

Foundation Medicine provides comprehensive genomic profiling for solid tumors and hematologic malignancies, supporting precision oncology and personalized cancer treatment strategies.

7. Agilent Technologies, Inc.

Agilent offers molecular diagnostic solutions for oncology, including gene expression profiling and biomarker analysis, aiding cancer diagnosis and targeted therapy decision-making.

8. Bio-Rad Laboratories, Inc.

Bio-Rad develops molecular diagnostic assays for oncology, utilizing PCR and droplet digital PCR technologies for sensitive cancer detection and monitoring.

9. Becton, Dickinson and Company (BD)

BD provides molecular diagnostic systems and assays for cancer detection, focusing on accuracy, speed, and integration into clinical workflows.

10. Myriad Genetics, Inc.

Myriad Genetics offers molecular diagnostic tests for hereditary cancers and tumor profiling, guiding prevention strategies and personalized oncology treatment plans.

How Big is the Oncology Molecular Diagnostics Market 2025: FAQs